03-Nov-2026 15:51:06

NEULAND LABORATORIES Q2 FY27 ; NET PROFIT DOWN 47% AT ₹52 CR (YOY), DOWN 65% (QOQ)

REVENUE DOWN 13% AT ₹450 CR (YOY), DOWN 30% (QOQ) EBITDA DOWN 37% AT ₹98 CR (YOY), DOWN 56% (QOQ) MARGINS AT 21.7% VS 30.2% (YOY), 34.7% (QOQ)

NEULAND LAB LTD.